Latest Breaking News On - Company or unicycive - Page 2 : comparemela.com
LOS ALTOS, Calif., March 25, 2024 (GLOBE NEWSWIRE) Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that multiple presentations will be delivered on the Company’s product candidates, oxylanthanum carbonate (OLC) and UNI-494, at the 61st European Renal Association (ERA) Congress taking place May 23-26, 2024, in Stockholm, Sweden. Shalabh Gupta, MD, Chief Execu
United-statesStockholmSwedenUnited-kingdomSatya-medicherlaShalabh-guptaLinkedinYoutubeExchange-commissionEuropean-renal-associationDrug-administrationNasdaq